These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 8199874)

  • 1. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy.
    Namba T; Morimoto K; Sato K; Yamada N; Kuroda S
    Brain Res; 1994 Feb; 638(1-2):36-44. PubMed ID: 8199874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat.
    Kodama M; Yamada N; Sato K; Kitamura Y; Koyama F; Sato T; Morimoto K; Kuroda S
    Eur J Pharmacol; 1999 Jun; 374(1):11-9. PubMed ID: 10422635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy.
    Löscher W; Rundfeldt C; Hönack D
    Eur J Neurosci; 1993 Nov; 5(11):1545-50. PubMed ID: 7904524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures.
    Dürmüller N; Craggs M; Meldrum BS
    Epilepsy Res; 1994 Feb; 17(2):167-74. PubMed ID: 8194512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy.
    Hara H; Yamada N; Kodama M; Matsumoto Y; Wake Y; Kuroda S
    Eur J Pharmacol; 2006 Feb; 531(1-3):59-65. PubMed ID: 16403498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-additive anticonvulsant effect of memantine and NBQX in kindled rats.
    Löscher W; Hönack D
    Eur J Pharmacol; 1994 Jul; 259(2):R3-5. PubMed ID: 7957602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
    Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
    Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates.
    Meldrum BS; Craggs MD; Dürmüller N; Smith SE; Chapman AG
    Epilepsy Res Suppl; 1992; 9():307-11. PubMed ID: 1337444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats.
    Namba T; Morimoto K; Yamada N; Otsuki S
    Pharmacol Biochem Behav; 1993 Oct; 46(2):275-81. PubMed ID: 8265681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of 2-chloroadenosine against the development of amygdala kindling and on amygdala-kindled seizures.
    Abdul-Ghani AS; Attwell PJ; Bradford HF
    Eur J Pharmacol; 1997 May; 326(1):7-14. PubMed ID: 9178649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of fully kindled seizure and retardation of kindling acquisition by YM928 in the rat kindling model of epilepsy.
    Yamashita H; Ohno K; Inami H; Shishikura J; Sakamoto S; Okada M; Yamaguchi T
    Eur J Pharmacol; 2004 Jun; 494(2-3):147-54. PubMed ID: 15212968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of the anticonvulsant effect of gamma-aminobutyric acid agonists in the feline kindling model of epilepsy.
    Morimoto K; Sanei T; Sato K
    Epilepsia; 1993; 34(6):1123-9. PubMed ID: 8243367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant effects of intra-hippocampal injection of TRH in amygdala kindled rats.
    Wan RQ; Noguera EC; Weiss SR
    Neuroreport; 1998 Mar; 9(4):677-82. PubMed ID: 9559937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine treatment during amygdala-kindled seizure development fails to inhibit seizures and diminishes subsequent anticonvulsant efficacy.
    Postma T; Krupp E; Li XL; Post RM; Weiss SR
    Epilepsia; 2000 Dec; 41(12):1514-21. PubMed ID: 11114208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of olfactory bulb kindling as a model for evaluation of antiepileptics.
    Fujiwara A; Watanabe Y; Takechi K; Ishikawa T; Kaida Y; Akagi M; Kamei C
    Epilepsia; 2010 Mar; 51(3):445-53. PubMed ID: 19845738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.